Ivanna Diaz

Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement All articles in this manuscript are available from PubMed and Embase. Supporting Information Filename Description liv70694-sup-0001-TableS1-S4-FigureS1-S7.docxWord 2007 document , 56.8 MB Table S1: Main characteristics of the included studies stratified by AILD subtype. Table S2: Timing of SLD assessment relative to corticosteroid exposure and reporting of biochemical response in AIH studies.

Please review our Terms and Conditions of Use and check box below to share full-text version of article. I have read and accept the Wiley Online Library Terms and Conditions of Use Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.

Randomised controlled trials of metabolic dysfunction-associated steatohepatitis (MASH) are highly concentrated in high-income countries. Reporting of data on race and ethnicity in MASH trials is suboptimal, although it has improved in recent years. Female and Hispanic/Latino representation has improved in recent years, but White participation remains high and is increasing over time, resulting in low representation of racial minorities.